Skip to main content
  • Image
    𝗡𝗼𝗕𝗼𝗖𝗮𝗽 𝗙𝗶𝗻𝗮𝗹 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀’ 𝗪𝗲𝗯𝗶𝗻𝗮𝗿: 𝗙𝗿𝗼𝗺 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗖𝗮𝗽𝗶𝘁𝗮𝗹!

For Europe's MedTech start-ups and SMEs, a CE certificate under the MDR or IVDR has become a question of survival, not only compliance. Notified-body timelines, clinical-evidence costs and regulatory changes determine when a product reaches the market, and investors price every one of them.

NoBoCap has worked to increase notified-body capacity and help manufacturers become better prepared through training, e-tools and structured dialogue between notified bodies, regulators and industry.

Through training, e-tools and structured dialogue between notified bodies, regulators and industry, NoBoCap has worked to increase notified body capacity and help manufacturers become better prepared.

💡 Our final investors’ webinar connects regulatory readiness with access to capital, exploring what certification means to investors and how companies can turn a solid certification pathway into a stronger investment case.

Investors, innovators, the NoBoCap Community and experts in HTA, remote health and digital innovation will discuss:
🔹 𝗙𝗿𝗼𝗺 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗺𝗮𝗿𝗸𝗲𝘁 𝗿𝗲𝗮𝗱𝗶𝗻𝗲𝘀𝘀: notified-body capacity, HTA evidence, validation at scale and digital innovation support.
🔹 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗿𝗶𝘀𝗸: how investors assess regulatory challenges during due diligence.
🔹 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀: which public and private funding routes fit each stage of certification.

📅 𝟮𝟯 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲
🕒 𝟭𝟱:𝟬𝟬–𝟭𝟳:𝟬𝟬 𝗖𝗘𝗧
💻 𝗢𝗻𝗹𝗶𝗻𝗲
🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄: https://short.do/DjtT8t

#NoBoCap project is co-funded by the European Union through the #EU4Health programme.

 

x

User login